New Lung Cancer Treatment Cuts Death Risk by 34%

A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope.

Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.